Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 8.97
Day High 8.92
Open:9.20
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Investor Expectations to Drive Momentum within Ingevity, First Industrial Realty Trust, ImmunoGen, PriceSmart, Pacific Gas & Electric, and Procter & Gamble -- Discovering Underlying Factors of Influence
GlobeNewswire - Mon Aug 6, 6:45AM CDT
GlobeNewswire - CMTX
Mon Aug 6, 6:45AM CDT
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ingevity Corporation (NYSE:NGVT), First Industrial Realty Trust, Inc. (NYSE:FR), ImmunoGen, Inc. (NASDAQ:IMGN), PriceSmart, Inc. (NASDAQ:PSMT), Pacific Gas & Electric Co. (NYSE:PCG), and Procter & Gamble Company (NYSE:PG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
ImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth Conference
BusinessWire - Tue Jul 31, 3:30PM CDT
BusinessWire - CMTX
Tue Jul 31, 3:30PM CDT
ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will present at the upcoming Canaccord Genuity Growth Conference. The presentation is scheduled for 8:30 a.m. ET on August 8, 2018.
ImmunoGen Reports Recent Progress and Second Quarter 2018 Operating Results
BusinessWire - Fri Jul 27, 5:47AM CDT
BusinessWire - CMTX
Fri Jul 27, 5:47AM CDT
--Encouraging Combination Data Reported from FORWARD II Expansion Cohort of Mirvetuximab with Avastin(R); Initial Data from Expansion Cohort in Combination with Keytruda(R) to be Presented at ESMO
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 8.70 +4.14% increase
on 09/17/18
Period Open:9.32
Price movement based on the high, low and last over the given period.
10.37 -12.63% decrease
on 09/04/18
-0.26 (-2.79%) decrease
since 08/21/18
3-Month 8.38 +8.10% increase
on 08/09/18
Period Open:11.68
Price movement based on the high, low and last over the given period.
12.31 -26.40% decrease
on 06/25/18
-2.62 (-22.43%) decrease
since 06/21/18
52-Week 4.80 +88.75% increase
on 11/03/17
Period Open:6.50
Price movement based on the high, low and last over the given period.
13.41 -32.44% decrease
on 03/26/18
+2.56 (+39.38%) increase
since 09/21/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement